New Horizon Health's high P/S ratio is backed by its robust projected revenue growth, outpacing the rest of the Healthcare sector. Shareholders are optimistic about future revenues, with a low likelihood of a significant share price drop. However, investors should note 2 warning signs.
诺辉健康股票讨论区
The future star. Now is the time to ambush for the potentially doubled valuation in the dual track of medical care and consumption.
暂无评论